Abstract

An efficient palladium-catalyzed intramolecular carbopalladation/cyclization cascade toward tetra- and pentacyclic N-fused heterocycles has been developed. This transformation proceeds via the palladium-catalyzed coupling of aryl halides with internal propargylic esters or ethers followed by the 5-endo-dig cyclization leading to polycyclic pyrroloheterocycles in moderate to excellent yields.
Nitrogen-containing heteroaromatic molecules and their analogues are pharmaceutically significant scaffolds, widely present in naturally occurring and synthetic biologically active molecules.1 For example, molecules containing an indolizine motif, such as Lamellarin D2 and other closely related cores,3 exhibit a wide array of biological activities, including human DNA topoisomerase I inhibition,4 ability to reverse multidrug resistance,5 and to induce apoptosis through a mitochondria mediated pathway toward broad range of cancer cell lines.6 These significant biological activities brought substantial attention to the synthesis of Lamellarins and their analogues.7,8 Although several routes toward their core exist, new methods allowing for the efficient construction of heterocycles, particularly those with modified core and different substitution patterns, are in high demand. We have recently reported a two-component coupling methodology toward fully substituted N-fused heterocycles.9,10 Although quite general with respect to the heterocyclic core, this approach is limited to the synthesis of bicyclic and tricyclic heteroaromatic molecules only (eq 1). Herein, we report a novel Pd-catalyzed arylation cyclization cascade that allows for easy assembly of various tetra-
![]() |
(1) |
and penta-cyclic isochromanone-annelated and other heterocycles.
We envisioned, that internal Ar-Pd-X species would undergo carbopalladation of the propargylic moiety of 1 with subsequent 5-endo-dig cyclization to produce 2 (Table 1). This idea was tested on cyclization of easily available propargyl-containing pyridine 111 in the presence of PdCl2(PPh3)2 catalyst. However, only trace amounts of desired product 2 were observed (Table 1, entries 1-3). Switching to PdCl2(MeCN)2 catalyst did not provide any improvement of reaction outcome (entries 4-6). However, employment of the ligand-free catalyst Pd(OAc)2 led to considerable enhancement of the reaction yields (entries 7-9). Solvent and concentration screening revealed the optimal conditions (entry 12).
Table 1.
Optimization of Reaction Conditionsa
![]() | |||||
|---|---|---|---|---|---|
| entry | X | Pd | base | solvent | yield, %b |
| 1 | Br | PdCl2(PPh3)2 | Cs2CO3 | NMP | - |
| 2 | Br | PdCl2(PPh3)2 | K3PO4 | NMP | - |
| 3 | Br | PdCl2(PPh3)2 | K2CO3 | NMP | traces |
| 4 | Br | PdCl2(MeCN)2 | Cs2CO3 | NMP | - |
| 5 | Br | PdCl2(MeCN)2 | K3PO4 | NMP | - |
| 6 | Br | PdCl2(MeCN)2 | K2CO3 | NMP | traces |
| 7 | Br | Pd(OAc)2 | Cs2CO3 | NMP | 25 |
| 8 | Br | Pd(OAc)2 | K3PO4 | NMP | 32 |
| 9 | Br | Pd(OAc)2 | K2CO3 | NMP | 37 |
| 10 | Br | Pd(OAc)2 | K2CO3 | DMF | 72c,d |
| 11 | Br | Pd(OAc)2 | K2CO3 | NMP | 68c,d |
| 12 | Br | Pd(OAc)2 | K2CO3 | DMA | 80c,d |
| 13 | I | Pd(OAc)2 | K2CO3 | DMA | 21c,d |
Reactions were run in the presence of 5 mol % of Pd-catalyst in appropriate solvent (0.5M) at 130 °C for 8 hours unless otherwise noted.
GC/MS yields.
Reactions was performed in appropriate solvent (0.33M) at 130 °C for 8 hours.
Isolated yield.
With these optimized conditions in hand, the scope of this cascade cyclization was examined (Table 2). Hence, benzyloxy-propargylic esters 1, possessing different alkyl (entries 1-3), alkenyl (entry 4), aryl (entries 5-7) substituents at the triple bond underwent smooth conversion to give the corresponding polycyclic heterocycles 2a-g in good yields. The generality of this transformation was further extended by employment of a number of functionalized benzyloxy-propargylic esters that smoothly were converted into the corresponding polycyclic N-fused heterocycles 2h-k (entries 8-11). Importantly, this transformation performed with comparable efficiency with other heterocyclic cores; isoquinoline and quinoline propargylic ester were effectively transformed to the pentacyclic N-fused heterocycles 2l and 2m, respectively (entries 12, 13).
Table 2.
Carbopalladation/Cyclization Reaction of Propargylic Esters 1a
![]() | |||||
|---|---|---|---|---|---|
| entry | 1 | 2 | yield, % b | ||
| 1 |
|
1a |
|
2a | 80 |
| 2 |
|
1b |
|
2b | 65 |
| 3 |
|
1c |
|
2c | 71 |
| 4 |
|
1d |
|
2d | 70 |
| 5 |
|
1e |
|
2e | 88 |
| 6 |
|
1f |
|
2f | 76 |
| 7 |
|
1g |
|
2g | 84 |
| 8 |
|
1h |
|
2h | 91 |
| 9 |
|
1i |
|
2i | 64 |
| 10 |
|
1j |
|
2j | 90 |
| 11 |
|
1k |
|
2k | 73 |
| 12 |
|
1l |
|
2l | 58 |
| 13 |
|
1m |
|
2m | 72 |
All reactions were performed on 0.15 mmol scale in DMA (0.33 M) at 100 to 130 °C for time specified in the Supporting Information.
Yield of the isolated product after flash chromatography on silica gel.
Furthermore, we found that propargylic ethers 312 could also be utilized in this transformation providing access to another polycyclic scaffold, employing slightly modified reaction conditions13 (Table 3). Interestingly, this reaction proved even more general with respect to the functional group compatibility (Table 3, entries 1-6). Pentacyclic heterocycle 4g was also efficiently obtained using this methodology.
Table 3.
Carbopalladation/Cyclization Reaction of Propargylic Ethers 3a
![]() | |||||
|---|---|---|---|---|---|
| entry | 3 | 4 | yield, %b | ||
| 1 |
|
3a |
|
4a | 63c |
| 2 |
|
3b |
|
4b | 26c |
| 3 |
|
3c |
|
4c | 38c |
| 4 |
|
3d |
|
4d | 35c |
| 5 |
|
3e |
|
4e | 64c |
| 6 |
|
3f |
|
4f | 47c |
| 7 |
|
3g |
|
4g | 70c |
| 8 |
|
3h |
|
4h | 83c |
| 9 |
|
3i |
|
4i | 71d |
| 10 |
|
3j |
|
4j | 64d |
| 11 |
|
3k |
|
4k | 68d |
| 12 |
|
3l |
|
4l | 48d |
| 13 |
|
3m |
|
4m | 83d |
All reactions were performed on 0.15 mmol scale in appropriate solvent (0.33 M) at 120 to 135 °C for time specified in the Supporting Information.
Isolated yield.
Reaction conditions A: Pd(OAc)2 (5 mol %), K2CO3 (2.0 equiv), n-Bu4NCl (1.0 equiv), DMF, 120 °C.
Reaction conditions B: Pd(OAc)2 (5 mol %), K2CO3 (2.0 equiv), LiCl (1.0 equiv), p-xylene, 135 °C.
Notably, this transformation could also be successfully performed on the carbocyclic analog, giving access to the fused indenofuran derivative 4h (entry 8). Propargylic silyl ethers 3i-m also proved efficient to undergo the carbopalladation/cyclization sequence, thus affording access toward novel silacyclic scaffolds (entries 8-13).9
In summary, we have developed a new synthetic protocol for rapid and efficient assembly of three distinct tetra- and pentacyclic cores from easily accessible starting materials. This cascade carbopalladation/cyclization approach is complementary to the previously developed methods10,11,14 toward multi-substituted N-fused heterocycles.
Supplementary Material
Acknowledgments
We gratefully acknowledge the financial support of the National Institute of Health (GM-64444).
Footnotes
Supporting Information Available Experimental details and characterization data for all new compounds is available free of charge via the Internet at http://pubs.acs.org.
References
- 1.Fan H, Peng J, Hamann MT, Hu JF. Chem Rev. 2008;108:264. doi: 10.1021/cr078199m. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Facompre M, Tardy C, Bal-Mahieu C, Colson P, Perez C, Manzanares I, Cuevas C, Bailly C. Cancer Res. 2003;63:7392. [PubMed] [Google Scholar]
- 3.(a) Bailly C. Curr Med Chem Anti-Cancer Agents. 2004;4:363. doi: 10.2174/1568011043352939. [DOI] [PubMed] [Google Scholar]; (b) Pla D, Francesch A, Calvo P, Cuevas C, Aligue R, Albericio F, Alvarez M. Bioconjugate Chem. 2009;20:1100. doi: 10.1021/bc800503k. [DOI] [PubMed] [Google Scholar]
- 4.Marco E, Laine W, Tardy C, Lansiaux A, Iwao M, Ishibashi F, Bailly C, Gago F. J Med Chem. 2005;48:3796. doi: 10.1021/jm049060w. [DOI] [PubMed] [Google Scholar]
- 5.(a) Chittchang M, Batsomboon P, Ruchirawat S, Ploypradith P. ChemMedChem. 2009;4:457. doi: 10.1002/cmdc.200800339. [DOI] [PubMed] [Google Scholar]; (b) Pla D, Marchal A, Olsen CA, Francesch A, Cuevas C, Albericio F, Alvarez M. J Med Chem. 2006;49:3257. doi: 10.1021/jm0602458. [DOI] [PubMed] [Google Scholar]
- 6.(a) Ballot C, Kluza J, Lancel S, Martoriati A, Hassoun SM, Mortier L, Vienne JC, Briand G, Formstecher P, Bailly C, Neviere R, Marchetti P. Apoptosis. 2010;15:769. doi: 10.1007/s10495-010-0471-2. [DOI] [PubMed] [Google Scholar]; (b) Ballot C, Kluza J, Martoriati A, Nyman U, Formstecher P, Joseph B, Bailly C, Marchetti P. Mol Cancer Ther. 2009;8:3307. doi: 10.1158/1535-7163.MCT-09-0639. [DOI] [PubMed] [Google Scholar]
- 7.See for example: Ohta T, Fukuda T, Ishibashi F, Iwao M. J Org Chem. 2009;74:8143. doi: 10.1021/jo901589e.Pla D, Marchal A, Olsen CA, Albericio F, Alvarez M. J Org Chem. 2005;70:8231. doi: 10.1021/jo051083a.
- 8.For recent synthetic approches toward novel hybrids, see: Ploypradith P, Petchmanee T, Sahakitpichan P, Litvinas ND, Ruchirawat S. J Org Chem. 2006;71:9440. doi: 10.1021/jo061810h.Shen L, Yang X, Yang B, He Q, Hu Y. Eur J Med Chem. 2010;45:11. doi: 10.1016/j.ejmech.2009.09.017.
- 9.For silyl ether tether approach in Pd-catalyzed biaryl coupling, see Huang C, Gevorgyan V. Am Chem Soc. 2009;131:10844. doi: 10.1021/ja904791y.Huang C, Gevorgyan V. Org Lett. 2010;12:2442. doi: 10.1021/ol100924n.
- 10.Chernyak D, Skontos C, Gevorgyan V. Org Lett. 2010;12:3242. doi: 10.1021/ol1011949. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.For transition-metal catalyzed cycloisomerization approaches toward N-fused pyrroloheterocycles, see Seregin IV, Gevorgyan V. J Am Chem Soc. 2006;128:12050. doi: 10.1021/ja063278l.Seregin IV, Schammel AW, Gevorgyan V. Org Lett. 2007;9:3433. doi: 10.1021/ol701464j.Smith CR, Bunnelle EM, Rhodes AJ, Sarpong R. Org Lett. 2007;9:1169. doi: 10.1021/ol0701971.Hardin AR, Sarpong R. Org Lett. 2007;9:4547. doi: 10.1021/ol701973s.Yan B, Zhou Y, Zhang H, Chen J, Liu Y. J Org Chem. 2007;72:7783. doi: 10.1021/jo070983j.
- 12.See Supporting Information for the detailed preparative procedures.
- 13.Jeffery T. Tetrahedron Lett. 1985;26:2667. [Google Scholar]
- 14.Kel'in AV, Sromek AW, Gevorgyan V. J Am Chem Soc. 2001;123:2074. doi: 10.1021/ja0058684.Schwier T, Sromek AW, Yap DML, Chernyak D, Gevorgyan V. J Am Chem Soc. 2007;129:9868. doi: 10.1021/ja072446m.Seregin IV, Schammel AW, Gevorgyan V. Tetrahedron. 2008;64:6876. doi: 10.1016/j.tet.2008.04.023. For a catalyst-free approach toward indolizines, see: Chernyak D, Gadamsetty SB, Gevorgyan V. Org Lett. 2008;10:2307. doi: 10.1021/ol8008705.
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.




